The page is the record's research on the issuer — no analyst, no rating, no view. # Aclaris Therapeutics, Inc. (NASDAQ: ACRS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Aclaris Therapeutics, Inc. is listed on NASDAQ under ticker ACRS, with ISIN US00461U1051 and LEI 5493000B2LQ9QTW1DF52. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its segment is not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 61 filings in the twelve months to 2026-11-08, across 32 filing days. The median gap between filing days is 7 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. The latest filing is a results filing dated 2026-11-05, 3 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days. By type, the record holds 28 directors' dealings, 12 regulatory filings, 9 results, 7 corporate news, 3 AGM or EGM filings and 2 prospectuses. The NASDAQ median is 52 filings and the sector median is 63.0 filings. ## Auditor The auditor of record is PricewaterhouseCoopers LLP, located in Philadelphia, Pennsylvania. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://data.sec.gov/submissions/CIK0001557746.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/ACRS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1557746/000110465926020540/acrs-20251231x10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ACRS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ACRS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp